Treatment with small molecules, such as 1′-acetoxychavicol acetate (ACA) [81], plumbagin [82], and allicin [83], significantly inhibited STAT3 through induction of SHP-1 in several types of cancer cells, including breast cancer, gastric cancer, and cholangiocarcinoma. This evidence concerns the gene NR0B2 and breast carcinoma.